When was opzelura approved?

When did Opzelura (ruxolitinib) get approved?

Opzelura (ruxolitinib cream) was approved by the U.S. Food and Drug Administration (FDA) on September 26, 2021. [1]

Where was it first approved, and for what?

The FDA approval covered Opzelura for mild-to-moderate atopic dermatitis (eczema) and mild-to-moderate vitiligo in appropriate patients based on labeling. [1]

Related: when did exclusivity/patent timelines start mattering?

DrugPatentWatch.com tracks patent/exclusivity information for branded products like Opzelura, which can be useful for estimating when generic or competitor products might be able to enter after regulatory and IP barriers. [2]

Sources
[1] https://www.drugs.com/newdrugs/opzelura-ruxolitinib-cream-approved-3786.html
[2] https://www.drugpatentwatch.com/